https://www.chiesi.com/it.html2026-10-05T08:02:31.213Zhttps://www.chiesi.com/it/cookies.html2026-09-27T16:58:22.388Zhttps://www.chiesi.com/it/chi-siamo.html2026-10-06T10:57:55.227Zhttps://www.chiesi.com/it/chi-siamo/la-nostra-storia.html2026-10-01T12:26:44.097Zhttps://www.chiesi.com/it/chi-siamo/chi-siamo-oggi.html2026-09-30T10:31:36.827Zhttps://www.chiesi.com/it/chi-siamo/etica-e-trasparenza.html2026-10-06T14:26:07.607Zhttps://www.chiesi.com/it/chi-siamo/etica-e-trasparenza/clinical-trial-transparency-and-data-sharing.html2026-09-25T07:51:45.464Zhttps://www.chiesi.com/it/chi-siamo/etica-e-trasparenza/report-paesi-efpia.html2026-10-02T10:32:53.149Zhttps://www.chiesi.com/it/chi-siamo/etica-e-trasparenza/report-paesi-efpia/svizzera.html2026-10-02T09:52:28.765Zhttps://www.chiesi.com/it/chi-siamo/la-nostra-governance.html2026-10-06T13:59:32.689Zhttps://www.chiesi.com/it/certification-notice.html2026-09-29T07:15:21.141Zhttps://www.chiesi.com/it/contattaci.html2026-09-28T08:46:49.102Zhttps://www.chiesi.com/it/contattaci/chiesi-nel-mondo.html2026-09-28T08:25:54.957Zhttps://www.chiesi.com/it/lavora-con-noi.html2026-09-30T09:56:36.288Zhttps://www.chiesi.com/it/media-hub.html2026-10-02T10:23:49.273Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa.html2026-09-27T17:37:20.766Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/filsuvez-approvazione-swissmedic-epidermolisi-bollosa.html2026-09-18T12:53:27.087Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/crescita-sostenibile-2025-risultati-finanziari-valore-condiviso.html2026-09-18T12:53:27.147Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/pmdi-basso-impatto-sviluppo-clinico-sottomissione-regolatoria.html2026-09-18T12:53:27.303Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-arbor-biotechnologies-partnership-gene-editing-malattie-rare.html2026-09-18T12:53:27.354Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/ampliamento-sito-industriale-la-chaussee-saint-victor-soluzioni-respiratorie-sostenibili.html2026-09-18T12:53:27.406Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/accordo-licenza-chiesi-aliada-abbvie-malattie-lisosomiali.html2026-09-18T12:53:27.457Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/carbon-minimal-inhaler-cmi-equivalenza-terapeutica-bts-winter-meeting.html2026-09-18T12:53:27.509Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/elfabrio-parere-positivo-chmp-somministrazione-quattro-settimane-ue.html2026-09-18T12:53:27.562Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-bespak-produzione-inalatori-basse-emissioni-carbonio-regno-unito.html2026-09-18T12:53:27.612Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/elfabrio-approvazione-commissione-europea-somministrazione-quattro-settimane.html2026-09-18T12:53:27.665Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-global-rare-diseases-parere-positivo-chmp-lojuxta.html2026-09-18T12:53:27.717Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-sceglie-salesforce-agentforce-life-sciences.html2026-09-18T12:53:27.768Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-solidi-risultati-finanziari-sostenibilita-esercizio-2025.html2026-09-18T12:53:27.821Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-annuncia-la-nuova-presidente-e-il-nuovo-vicepresidente.html2026-09-18T12:53:27.925Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-acquisisce-kalvista-pharmaceuticals-rafforzando-il-portafoglio-globale-nelle-malattie-rare.html2026-09-18T12:53:27.874Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-completa-acquisizione-di-kalvista-pharmaceuticals.html2026-09-18T12:53:27.976Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/impatto-cambiamenti-climatici-patologie-respiratorie.html2026-09-18T12:53:26.026Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/oscar-di-bilancio-categoria-societa-benefit.html2026-09-18T12:53:26.07Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/global-rare-diseases-approvazione-fda-gel-topico-epidermolisi-bollosa.html2026-09-18T12:53:26.116Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-oak-hill-bio-ohb-607-terapia-neonatale.html2026-09-18T12:53:26.16Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/past-present-future.html2026-09-18T12:53:26.214Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-annuncia-scomparsa-presidente-onorario-dottor-paolo-chiesi.html2026-09-18T12:53:26.258Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/nuovo-contratto-integrativo-italia.html2026-09-18T12:53:26.361Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/inalatori-basso-impatto-ambientale-traguardo.html2026-09-18T12:53:26.407Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/collaborazione-gossamer-bio-ipertensione-arteriosa-polmonare.html2026-09-18T12:53:26.502Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/fatturato-2023.html2026-09-18T12:53:26.452Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/karolinska-institutet-affrontare-sfide-sanitarie.html2026-09-18T12:53:26.546Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/primo-paziente-arruolato-nello-studio-ohb-607-di-fase-2b.html2026-09-26T21:17:29.836Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/sostenibilita-strategia-creare-valore-condiviso-approfondimenti-report-sostenibilita-2023.html2026-09-18T12:53:26.639Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/asma-persistente-un-innovativo-inalatore.html2026-09-18T12:53:20.875Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-e-la-prima-a-sottomettere-ad-ema-la-richiesta-di-autorizzazione-per-l-immissione-in-commercio-della-tripla-combinazione-icslabalama.html2026-09-18T12:53:21.189Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-potenzia-il-portfolio-asma-con-l-acquisizione-di-atopix-therapeutics.html2026-09-18T12:53:21.277Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/cresce-il-portfolio-chiesi-farmaceutici-in-area-cardiovascolare.html2026-09-18T12:53:21.007Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/gli-studi-internazionali-premiano-la-ricerca-italiana-sulla-bpco-e-di-chiesi-la-prima-tripla-associazione-fissa-extrafine-icslabalama-in-un-unico-inalatore-altamente-efficace-e-facile-da-usare.html2026-09-18T12:53:21.098Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/glybera-in-europa.html2026-09-18T12:53:21.462Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-chiude-il-2016-con-il-fatturato-in-crescita-e-consolida-la-propria-presenza-globale.html2026-09-18T12:53:21.419Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-e-una-delle-8-aziende-italiane-invitate-da-macron-al-french-international-summit-a-versailles.html2026-09-18T12:53:21.776Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-farmaceutici-s-p-a-conferma-un-trend-di-crescita-e-investimenti-per-il-2014.html2026-09-18T12:53:20.963Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-riceve-l-european-marketing-authorisation-per-trimbow-ics-laba-lama.html2026-09-18T12:53:21.552Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-riceve-l-opinione-positiva-del-chmp-per-lamzede-la-prima-terapia-per-l-alfa-mannosidosi-in-europa.html2026-09-18T12:53:21.731Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-si-conferma-top-employer-2018-per-l-italia-e-l-europa.html2026-09-18T12:53:21.687Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-presidente-del-consiglio-matteo-renzi-visita-il-centro-ricerche-di-parma.html2026-09-18T12:53:21.233Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/l-associazione-icslaba-per-inalazione-extrafine-riduce-le-esacerbazioni-in-bpco-piu-dell-associazione-labalama-uno-studio-comparativo-verso-broncodilatatore-singolo.html2026-09-18T12:53:21.052Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/l-europa-approva-holoclar-il-primo-farmaco-a-base-di-cellule-staminali-della-storia-ed-e-made-in-italy.html2026-09-18T12:53:20.919Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/lo-studio-tribute-dimostra-la-superiorita-di-trimbow-chiesi-su-ultibro-nella-riduzione-delle-riacutizzazioni-della-bpco-1-2.html2026-09-18T12:53:21.598Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/nuovo-studio-pubblicato-su-the-lancet-mostra-la-superiorita-della-tripla-associazione-fissa-extrafine-di-chiesi-per-la-bpco.html2026-09-18T12:53:21.643Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/per-la-seconda-volta-l-associazione-tripla-extrafine-ics-laba-lama-di-chiesi-guadagna-le-pagine-di-the-lancet-con-la-pubblicazione-dello-studio-trinity.html2026-09-18T12:53:21.375Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/report-gold-2017-chiesi-farmaceutici-evidenzia-alcune-importanti-lacune-del-documento.html2026-09-18T12:53:21.329Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/the-lancet-pubblica-i-risultati-dello-studio-trilogy-di-chiesi-farmaceutici.html2026-09-18T12:53:21.144Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/trimbow-e-la-prima-tripla-associazione-in-un-singolo-inalatore-per-il-trattamento-della-bpco-a-ricevere-l-opinione-positiva-del-chmp-in-europa.html2026-09-18T12:53:21.507Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/mario-melazzini-direttore-generale-di-aifa-incontra-i-giovani-ricercatori-del-centro-ricerche-di-chiesi-farmaceutici.html2026-09-18T12:53:21.819Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-prima-azienda-farmaceutica-italiana-per-investimenti-in-ricerca-e-sviluppo.html2026-09-18T12:53:21.863Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-al-via-il-cantiere-per-il-futuro-headquarters-del-gruppo.html2026-09-18T12:53:21.907Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-riceve-la-european-marketing-authorisation-per-la-prima-terapia-farmacologica-per-l-alfa-mannosidosi.html2026-09-18T12:53:21.952Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-e-holostem-annunciano-l-ottenimento-della-designazione-orfana-di-gplscd01-per-il-trattamento-della-deficienza-di-cellule-staminali-limbali-lscd-da-parte-dell-fda.html2026-09-18T12:53:21.999Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-farmaceutici-estende-la-propria-partnership-con-protalix-biotherapeutics-acquisendo-i-diritti-esclusivi-per-gli-stati-uniti-per-lo-sviluppo-e-la-commercializzazione-di-prx-102-pegunigalsidase-alfa-per-il-trattamento-della-malattia-di-fabry.html2026-09-18T12:53:22.045Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-acquisisce-nhco-nutrition-sas-e-rafforza-il-proprio-portafoglio-otc-in-francia.html2026-09-18T12:53:22.089Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/bpco-una-patologia-ancora-sottostimata-dagli-europei-manca-la-percezione-del-rischio-e-quanto-emerge-da-un-indagine-eurisko.html2026-09-18T12:53:22.134Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-farmaceutici-cambia-lo-statuto-in-lsocieta-benefitr.html2026-09-18T12:53:22.178Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-riceve-il-premio-eurordis-black-pearl-per-lrinnovazione-nellrambito-delle-malattie-rare.html2026-09-18T12:53:22.222Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/paolo-chiesi-insignito-della-laurea-honoris-causa-presso-il-karolinska-institutet-di-stoccolma.html2026-09-18T12:53:22.265Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-diventa-una-b-corporation-certificata.html2026-09-18T12:53:22.316Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/volontariato-aziendale-in-chiesi-farmaceutici-conclusa-la-5-edizione-di-everyone-of-us-is-different-everyone-of-us-is-chiesi.html2026-09-18T12:53:22.359Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-conferma-un-trend-positivo-della-performance-nel-2019.html2026-09-18T12:53:22.403Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-farmaceutici-annuncia-un-investimento-di-350-milioni-di-euro-per-il-primo-inalatore-spray-pmdi-con-ridotto-impatto-ambientale-per-asma-e-broncopneumopatia-cronica-ostruttiva-bpco.html2026-09-18T12:53:22.581Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-farmaceutici-e-gsk-parma-al-via-i-test-sierologici-gratuiti-per-i-dipendenti.html2026-09-18T12:53:22.806Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-group-si-aggiudica-il-diversity-leaders-award-2020.html2026-09-18T12:53:22.536Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-pubblicato-il-report-annuale-nel-2019-il-gruppo-sfiora-i-2-miliardi-e-ottiene-la-certificazione-b-corp.html2026-09-18T12:53:22.897Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-accoglie-la-visita-ufficiale-del-sottosegretario-di-stato-stanislao-di-piazza.html2026-09-18T12:53:23.078Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-aumenta-le-misure-in-atto-e-annuncia-nuovi-fondi-per-dipendenti-pazienti-e-operatori-sanitari-in-risposta-alla-pandemia-di-covid-19.html2026-09-18T12:53:22.763Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-e-moderna-collaborano-per-scoprire-sviluppare-e-commercializzare-terapie-basate-su-mrna-per-l-ipertensione-arteriosa-polmonare-iap.html2026-09-18T12:53:22.944Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-entra-nel-regime-di-adempimento-collaborativo-dell-agenzia-delle-entrate.html2026-09-18T12:53:22.625Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-si-conferma-top-employer-2020-in-italia-e-europa.html2026-09-18T12:53:22.715Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-sponsor-di-parma-capitale-della-cultura-2020.html2026-09-18T12:53:22.67Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-presidente-di-chiesi-farmaceutici-nominato-cavaliere-della-legion-drhonneur.html2026-09-18T12:53:22.989Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/la-tripla-terapia-in-formulazione-extrafine-in-un-unico-inalatore.html2026-09-18T12:53:22.492Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/thomas-eichholtz-e-il-nuovo-head-of-global-research-and-development-del-gruppo-chiesi.html2026-09-18T12:53:22.851Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/we-act-day-2019-chiesi-lancia-la-sfida-di-diventare-carbon-neutral-entro-il-2035.html2026-09-18T12:53:22.447Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/we-act-day-2020-torna-l-appuntamento-di-chiesi-verso-un-futuro-sostenibile.html2026-09-18T12:53:23.034Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/bilancio-sostenibilita-2024-chiesi-purpose-first.html2026-09-18T12:53:26.988Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/biotech-center-parma-opening.html2026-09-18T12:53:26.733Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-group-serna-bio-collaborazione-piccole-molecole-rna-malattie-respiratorie.html2026-09-18T12:53:27.037Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/crescita-2024-innovazione-sostenibilita.html2026-09-18T12:53:26.934Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/nuovi-amministratori-indipendenti-cda.html2026-09-18T12:53:26.834Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/nuovo-stabilimento-nerviano.html2026-09-18T12:53:26.883Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/presenta-novita-respiratorio-pazienti-decentralizzazione-carbon-minimal-inhaler.html2026-09-18T12:53:26.684Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/world-best-workplaces-2024.html2026-09-18T12:53:26.784Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/al-via-infermieri-a-viso-aperto-un-progetto-fotografico-per-mostrare-i-volti-e-le-storie-di-chi-ogni-giorno-e-al-fianco-dei-pazienti.html2026-09-18T12:53:23.313Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-group-si-aggiudica-il-diversity-leaders-award-2021.html2026-09-18T12:53:23.213Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-lancia-llrarte-della-curar-2c-un-viaggio-alla-scoperta-del-legame-tra-parma-2c-le-cure-officinali-e-la-farmaceutica.html2026-09-18T12:53:23.169Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/gruppo-chiesi-ema-approva-lrautorizzazione-allrimmissione-in-commercio-della-combinazione-extrafine-in-tripla-terapia-anche-per-il-trattamento-dellrasma-non-controllata-da-ics-laba.html2026-09-18T12:53:23.447Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/gruppo-chiesi-performance-in-crescita-nel-2020.html2026-09-18T12:53:23.492Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/headquarters-chiesi-una-casa-innovativa-sostenibile-e-a-misura-d-uomo-primo-edificio-nella-sua-categoria-certificato-leed-platinum-in-italia-al-centro-del-progetto-le-persone.html2026-09-18T12:53:23.401Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-firma-accordo-integrativo-all-avanguardia-sui-diritti-dei-lavoratori.html2026-09-18T12:53:23.357Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/kaia-health-e-il-gruppo-chiesi-annunciano-una-partnership-strategica-per-la-commercializzazione-dellrapp-kaia-copd-per-la-riabilitazione-polmonare-in-europa.html2026-09-18T12:53:23.259Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/premio-bellisario-maria-paola-chiesi-ospite-al-quirinale-in-occasione-della-visita-riservata-alle-mele-d-oro-2020.html2026-09-18T12:53:23.123Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/centro-ricerche-chiesi-10-anni-di-innovazione-scientifica-al-servizio-della-comunita.html2026-09-18T12:53:23.904Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-accelera-il-proprio-percorso-verso-la-piena-sostenibilita-2c-nonostante-la-pandemia-da-covid-19.html2026-09-18T12:53:23.767Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-ottiene-un-rating-esg-positivo-dallragenzia-indipendente-cerved-rating-agency.html2026-09-18T12:53:23.859Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/congresso-ers-2021-importanti-aggiornamenti-scientifici-sul-trattamento-dellrasma-e-della-bpco-al-simposio-organizzato-da-chiesi-lunlock-every-breath-finding-the-right-key-to-improve-respiratory-therapyr.html2026-09-18T12:53:23.813Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/covid-19-continua-lrimpegno-del-gruppo-chiesi-per-la-sicurezza-dei-suoi-dipendenti-e-della-comunita.html2026-09-18T12:53:23.581Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-invita-all-azione-contro-il-cambiamento-climatico-con-actionoverwords.html2026-09-18T12:53:23.721Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-riceve-l-autorizzazione-ue-per-nexthaler-nella-bpco.html2026-09-26T21:16:53.707Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/nuova-visual-identity-per-il-gruppo-chiesi-2c-alla-base-le-parole-e-le-esperienze-dei-pazienti.html2026-09-18T12:53:23.537Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/nuovo-assetto-organizzativo-per-chiesi-foundation.html2026-09-18T12:53:23.675Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-sottoscrive-il-manifesto-contro-la-violenza-di-genere.html2026-09-18T12:53:24.845Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-continua-a-crescere.html2026-09-18T12:53:24.17Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-porta-a-parma-il-futuro-della-medicina-con-il-nuovo-biotech-center-of-excellence.html2026-09-18T12:53:24.8Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/azioni-concrete-dal-gruppo-chiesi-per-un-futuro-piu-sano-e-sostenibile.html2026-09-18T12:53:24.316Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/azioni-in-supporto-alla-popolazione-afflitta-dalla-guerra.html2026-09-18T12:53:24.127Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/protalix-biotherapeutics-e-chiesi-global-rare-diseases-annunciano-i-risultati-topline-della-sperimentazione-clinica-di-fase-iii-balance-della-durata-di-24-mesi-su-prx-102-per-il-trattamento-della-malattia-di-fabry.html2026-09-18T12:53:24.225Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-acquisisce-il-pionieristico-portafoglio-di-anticorpi-monoclonali-terapeutici-contro-emap-ii-come-potenziale-trattamento-per-l-ipertensione-arteriosa-polmonare.html2026-09-18T12:53:24.271Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/primi-risultati-positivi-per-lo-sviluppo-dell-inalatore-spray-a-basso-impatto-ambientale-che-andra-a-beneficio-dei-pazienti-e-del-pianeta.html2026-09-18T12:53:24.363Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-annuncia-la-fine-del-mandato-di-ugo-di-francesco-come-ad-del-gruppo.html2026-09-18T12:53:24.407Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-riunisce-esperti-per-discutere-la-cura-dei-pazienti-affetti-da-patologie-ostruttive-e-presenta-una-nuova-opzione-di-trattamento-per-la-bpco-al-congresso-ers.html2026-09-18T12:53:24.617Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-si-ricertifica-come-b-corp-e-fissa-nuovi-e-piu-sfidanti-obiettivi-di-azione-entro-il-2025.html2026-09-18T12:53:24.663Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-e-aptar-collaborano-per-portare-sul-mercato-una-piattaforma-di-gestione-della-malattia-disease-management-platform-per-i-pazienti-affetti-da-asma-e-bpco.html2026-09-18T12:53:24.71Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-foundation-e-l-ospedale-di-parma-celebrano-la-giornata-mondiale-della-prematurita.html2026-09-18T12:53:24.754Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-group-comunica-di-non-essere-coinvolto-nelle-vicende-riguardanti-l-azienda-holostem.html2026-09-18T12:53:24.889Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/lrheadquarters-del-gruppo-chiesi-protagonista-della-monografia-lspazio-lavoro-architetturar-edizioni-electaarchitettura.html2026-09-18T12:53:23.993Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/un-nuovo-quadro-di-riferimento-clinico-ridefinisce-la-diagnosi-delle-riacutizzazioni-da-bpco.html2026-09-18T12:53:24.084Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-presenta-lparma-2030-la-citta-sostenibiler.html2026-09-18T12:53:23.948Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-punta-sui-farmaci-biologici-investimento-da-85-milioni-di-euro-per-un-polo-di-eccellenza-internazionale-a-parma.html2026-09-18T12:53:24.039Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-global-rare-diseases-annuncia-l-approvazione-da-parte-dell-fda-di-una-terapia-enzimatica-sostitutiva-per-l-alfa-mannosidosi.html2026-09-18T12:53:25.072Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-global-rare-diseases-e-protalix-biotherapeutics-ricevono-il-parere-positivo-del-chmp-su-pegunigalsidasi-alfa-per-il-trattamento-della-malattia-di-fabry.html2026-09-18T12:53:25.166Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-global-rare-diseases-presenta-i-risultati-a-lungo-termine-degli-studi-di-fase-3-balance-e-bright-sulla-malattia-di-fabry-al-19-worldsymposium-research-meeting.html2026-09-18T12:53:25.118Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-nomina-giuseppe-accogli-nuovo-ceo-del-gruppo.html2026-09-18T12:53:25.026Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-2022-di-chiesi-continua-la-crescita-del-gruppo-a-livello-internazionale.html2026-09-18T12:53:25.353Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/il-gruppo-chiesi-e-affibody-collaborano-per-sviluppare-e-commercializzare-trattamenti-innovativi-per-le-malattie-respiratorie.html2026-09-18T12:53:25.212Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/importanti-riconoscimenti-per-il-gruppo-chiesi-da-parte-del-carbon-disclosure-project-cdp-e-dell-agenzia-di-rating-cerved.html2026-09-18T12:53:24.981Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/play-the-rare-game-for-the-rare-ones-parte-da-parma-la-prima-catena-di-passaggi-virtuali-di-palla-ovale-per-sensibilizzare-sulle-malattie-rare.html2026-09-18T12:53:24.935Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/playtheraregame-la-campagna-di-sensibilizzazione-sulle-malattie-rare-presente-al-sei-nazioni-2023-a-roma.html2026-09-18T12:53:25.263Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/restore-to-impact-the-next-healthcare-landmark-for-innovation-and-future-oriented-competencies.html2026-09-18T12:53:25.308Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/accordo-haisco-pharmaceutical-inibitore-reversibile-dipeptidil-peptidasi-1-bronchiectasie.html2026-09-18T12:53:25.936Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/acquisizione-amryt-pharma.html2026-09-18T12:53:25.396Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/alessandro-chiesi-presidente-maria-paola-chiesi-vicepresidente.html2026-09-18T12:53:25.616Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/alluvione-emilia-romagna.html2026-09-18T12:53:25.528Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/autorizzazione-pegunigalsidasi-alfa-malattia-fabry.html2026-09-18T12:53:25.441Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/autorizzazione-prx-102-malattia-fabry.html2026-09-18T12:53:25.486Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/cambiamento-climatico-patologie-respiratorie.html2026-09-18T12:53:25.756Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/film-rare-land-alpha-mannosidosis.html2026-09-18T12:53:25.572Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/nest-partners-meeting-chiesi-foundation.html2026-09-18T12:53:25.801Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/partnership-day-2023.html2026-09-18T12:53:25.844Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/rapporto-oneri-cura-malattie-rare.html2026-09-18T12:53:25.889Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/report-sostenibilita-2022.html2026-09-18T12:53:25.661Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/restore-to-impact-award-ceremony.html2026-09-18T12:53:25.981Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/risultati-finanziari-met-anno-2023.html2026-09-18T12:53:25.711Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-porta-avanti-percorso-verso-inalatori-a-ridotta-impronta-carbonica-con-convalida-in-europa-delle-sottomissioni-regolatorie-per-tripla-terapia-in-singolo-inalatore-e-per-la-combinazione-ics-laba-in-pmdi-con-propellente-di-nuova-generazione.html2026-10-02T14:05:45.471Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-nomina-david-khougazian-chief-executive-officer-del-gruppo.html2026-10-02T15:50:04.909Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-global-rare-diseases-annuncia-approvazione-commissione-europea-lomitapide-capsule-uso-pediatrico-hofh.html2026-10-02T15:55:57.267Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/gruppo-chiesi-solida-performance-primo-semestre-2026-crescita-continui-investimenti-innovazione-impatto-economico-positivo-comunit.html2026-10-02T16:00:56.198Zhttps://www.chiesi.com/it/media-hub/comunicati-stampa/chiesi-ottiene-autorizzazione-immissione-in-commercio-in-europa-per-triplice-terapia-in-singolo-inalatore-erogata-tramite-nexthaler-per-trattamento-di-mantenimento-asma.html2026-10-02T15:33:15.375Zhttps://www.chiesi.com/it/media-hub/news.html2026-10-02T10:05:38.892Zhttps://www.chiesi.com/it/media-hub/news/alberto-paolo-e-andrea-chiesi-vincitori-del-premio-l-imprenditore-dellanno-2015.html2026-09-18T12:53:15.02Zhttps://www.chiesi.com/it/media-hub/news/chiesi-certificata-top-employer-anche-per-il-2017.html2026-09-18T12:53:15.062Zhttps://www.chiesi.com/it/media-hub/news/chiesi-cresce-a-due-cifre-ed-estende-la-propria-presenza-globale.html2026-09-18T12:53:14.807Zhttps://www.chiesi.com/it/media-hub/news/chiesi-farmaceutici-completa-lacquisizione-dei-diritti-di-commercializzazione-per-leuropa.html2026-09-18T12:53:15.106Zhttps://www.chiesi.com/it/media-hub/news/chiesi-farmaceutici-per-il-festival-verdi.html2026-09-18T12:53:15.268Zhttps://www.chiesi.com/it/media-hub/news/chiesi-riconfermata-top-employer.html2026-09-18T12:53:14.934Zhttps://www.chiesi.com/it/media-hub/news/chiesi-tra-le-prime-10-aziende-piu-ambite-dai-lavoratori.html2026-09-18T12:53:14.892Zhttps://www.chiesi.com/it/media-hub/news/festival-verdi-in-anteprima-i-titoli-2018.html2026-09-18T12:53:15.146Zhttps://www.chiesi.com/it/media-hub/news/foster-pmdi-indicato-per-la-bpco.html2026-09-18T12:53:14.851Zhttps://www.chiesi.com/it/media-hub/news/jerusalem-le-foto-di-scena-inedite.html2026-09-18T12:53:15.187Zhttps://www.chiesi.com/it/media-hub/news/la-traviata-di-busseto-occasione-per-gli-artisti-di-domani.html2026-09-18T12:53:15.309Zhttps://www.chiesi.com/it/media-hub/news/menzione-speciale-a-holoclar-al-premio-galeno.html2026-09-18T12:53:14.977Zhttps://www.chiesi.com/it/media-hub/news/stiffelio-cosi-e-nata-la-prima-opera-immersiva-in-italia.html2026-09-18T12:53:15.227Zhttps://www.chiesi.com/it/media-hub/news/benvenuti-a-windsor-terra-di-falstaff.html2026-09-18T12:53:15.35Zhttps://www.chiesi.com/it/media-hub/news/bio-europe.html2026-09-18T12:53:15.762Zhttps://www.chiesi.com/it/media-hub/news/chiesi-e-protalix-biotherapeutics-firmano-un-accordo-per-lo-sviluppo-e-la-commercializzazione-di-prx-102-pegunigalsidase-alfa-per-il-trattamento-della-malattia-di-fabry.html2026-09-18T12:53:15.682Zhttps://www.chiesi.com/it/media-hub/news/digital-transformation-in-chiesi-digital-safari-workshop-con-david-orban.html2026-09-18T12:53:15.804Zhttps://www.chiesi.com/it/media-hub/news/gualazzi-a-tu-per-tu-con-verdi.html2026-09-18T12:53:15.631Zhttps://www.chiesi.com/it/media-hub/news/messa-da-requiem-guida-all-ascolto.html2026-09-18T12:53:15.39Zhttps://www.chiesi.com/it/media-hub/news/messa-da-requiem-le-immagini-esclusive.html2026-09-18T12:53:15.431Zhttps://www.chiesi.com/it/media-hub/news/musica-ovunque-e-per-tutti-verdi-off.html2026-09-18T12:53:15.723Zhttps://www.chiesi.com/it/media-hub/news/omaggio-a-lella-costa-intelligenza-della-traviata.html2026-09-18T12:53:15.511Zhttps://www.chiesi.com/it/media-hub/news/verdi-in-crescendo.html2026-09-18T12:53:15.591Zhttps://www.chiesi.com/it/media-hub/news/verdiyoung-il-festival-e-per-tutte-le-eta-2017.html2026-09-18T12:53:15.471Zhttps://www.chiesi.com/it/media-hub/news/violetta-a-360.html2026-09-18T12:53:15.551Zhttps://www.chiesi.com/it/media-hub/news/31-milioni-di-dollari-per-startup-health-grazie-a-chiesi-group-e-altre-big-farma-internazionali.html2026-09-18T12:53:16.094Zhttps://www.chiesi.com/it/media-hub/news/attila-le-foto-esclusive.html2026-09-18T12:53:16.298Zhttps://www.chiesi.com/it/media-hub/news/chiesi-sigla-un-accordo-con-startup-health-primo-investimento-in-ambito-digitale.html2026-09-18T12:53:15.93Zhttps://www.chiesi.com/it/media-hub/news/chiesi-sostiene-la-mostra-il-terzo-giorno-dedicata-al-rapporto-tra-uomo-e-natura.html2026-09-18T12:53:15.887Zhttps://www.chiesi.com/it/media-hub/news/dietro-le-quinte-de-le-trouvere.html2026-09-18T12:53:16.217Zhttps://www.chiesi.com/it/media-hub/news/dietro-le-quinte-di-un-nuovo-festival-verdi.html2026-09-18T12:53:15.971Zhttps://www.chiesi.com/it/media-hub/news/global-corporate-development-apertura-dei-nuovi-uffici-a-boston.html2026-09-18T12:53:15.845Zhttps://www.chiesi.com/it/media-hub/news/macbeth-le-immagini-inedite.html2026-09-18T12:53:16.175Zhttps://www.chiesi.com/it/media-hub/news/un-giorno-a-busseto-un-giorno-di-regno.html2026-09-18T12:53:16.258Zhttps://www.chiesi.com/it/media-hub/news/verdi-a-domicilio.html2026-09-18T12:53:16.051Zhttps://www.chiesi.com/it/media-hub/news/verdi-macbeth.html2026-09-18T12:53:16.135Zhttps://www.chiesi.com/it/media-hub/news/verdi-off-is-back.html2026-09-18T12:53:16.011Zhttps://www.chiesi.com/it/media-hub/news/a-chiesi-il-premio-imprese-per-innovazione-e-menzioni-speciali-industria-4-0-e-sostenibilita.html2026-09-18T12:53:16.34Zhttps://www.chiesi.com/it/media-hub/news/il-gruppo-chiesi-firma-un-accordo-di-licenza-con-santhera-per-il-trattamento-della-sindrome-di-lhon.html2026-09-18T12:53:16.383Zhttps://www.chiesi.com/it/media-hub/news/parma-smart-city-un-protocollo-per-progettare-la-parma-del-futuro.html2026-09-18T12:53:16.425Zhttps://www.chiesi.com/it/media-hub/news/il-gruppo-chiesi-sigla-unropzione-di-licenza-con-inhibrx-per-lo-sviluppo-e-la-commercializzazione-di-inbrx-101-28aat-fc-29.html2026-09-18T12:53:16.467Zhttps://www.chiesi.com/it/media-hub/news/il-gruppo-chiesi-annuncia-la-finalizzazione-dellraccordo-di-licenza-con-santhera-per-raxoner-nel-lhon.html2026-09-18T12:53:16.51Zhttps://www.chiesi.com/it/media-hub/news/aida.html2026-09-18T12:53:16.55Zhttps://www.chiesi.com/it/media-hub/news/verdi-off-2019-la-musica-invade-la-citta.html2026-09-18T12:53:16.592Zhttps://www.chiesi.com/it/media-hub/news/luisa-miller.html2026-09-18T12:53:16.631Zhttps://www.chiesi.com/it/media-hub/news/i-due-foscari.html2026-09-18T12:53:16.671Zhttps://www.chiesi.com/it/media-hub/news/nabucco.html2026-09-18T12:53:16.711Zhttps://www.chiesi.com/it/media-hub/news/verdiyoung-il-festival-e-per-tutte-le-eta.html2026-09-18T12:53:16.751Zhttps://www.chiesi.com/it/media-hub/news/10-ottobre-buon-compleanno-maestro.html2026-09-18T12:53:16.79Zhttps://www.chiesi.com/it/media-hub/news/al-regio-nuove-prospettive-con-il-barezzi-festival.html2026-09-18T12:53:16.831Zhttps://www.chiesi.com/it/media-hub/news/al-regio-tutte-le-anime-della-danza.html2026-09-18T12:53:17.125Zhttps://www.chiesi.com/it/media-hub/news/chiesi-farmaceutici-e-holostem-terapie-avanzate-annunciano-il-trasferimento-di-holoclar-dal-gruppo-chiesi-ad-holostem.html2026-09-18T12:53:17.211Zhttps://www.chiesi.com/it/media-hub/news/da-0-a-99-anni-con-regioyoung-il-teatro-e-per-ogni-eta.html2026-09-18T12:53:16.878Zhttps://www.chiesi.com/it/media-hub/news/happiness-wellbeing-l-intervento-di-maria-paola-chiesi-in-vaticano.html2026-09-18T12:53:17.167Zhttps://www.chiesi.com/it/media-hub/news/il-gruppo-chiesi-annuncia-la-creazione-della-nuova-global-rare-diseases-business-unit-dedicata-alle-malattie-rare.html2026-09-18T12:53:17.085Zhttps://www.chiesi.com/it/media-hub/news/la-stagione-concertistica-realizzata-con-il-sostegno-di-chiesi.html2026-09-18T12:53:17.041Zhttps://www.chiesi.com/it/media-hub/news/quattro-titoli-del-900-per-la-stagione-lirica-2020.html2026-09-18T12:53:17Zhttps://www.chiesi.com/it/media-hub/news/the-b-change-online-l-instant-book-di-pharmastar.html2026-09-18T12:53:17.253Zhttps://www.chiesi.com/it/media-hub/news/verdi-2020-annunciati-i-titoli-del-festival.html2026-09-18T12:53:16.919Zhttps://www.chiesi.com/it/media-hub/news/xix-festival-verdi-un-edizione-da-record.html2026-09-18T12:53:16.959Zhttps://www.chiesi.com/it/media-hub/news/around-verdi.html2026-09-18T12:53:17.376Zhttps://www.chiesi.com/it/media-hub/news/chiesi-aderisce-a-unlock-the-change-il-movimento-di-imprese-b-corp-per-sbloccare-il-cambiamento.html2026-09-18T12:53:17.295Zhttps://www.chiesi.com/it/media-hub/news/chiesi-usa-inc-announces-fda-approval-of-bronchitol-mannitol-inhalation-powder.html2026-09-18T12:53:17.66Zhttps://www.chiesi.com/it/media-hub/news/ernani.html2026-09-18T12:53:17.617Zhttps://www.chiesi.com/it/media-hub/news/giornata-mondiale-della-prematurita-chiesi-in-prima-linea-per-i-bambini-prematuri.html2026-09-18T12:53:17.703Zhttps://www.chiesi.com/it/media-hub/news/il-primo-incontro-globale-per-lanciare-il-programma-di-regeneration-20-30-e-a-parma-il-15-e-16-ottobre.html2026-09-18T12:53:17.458Zhttps://www.chiesi.com/it/media-hub/news/italy-for-climate-chiesi-in-prima-linea-per-il-futuro-dellritalia.html2026-09-18T12:53:17.336Zhttps://www.chiesi.com/it/media-hub/news/macbeth.html2026-09-18T12:53:17.537Zhttps://www.chiesi.com/it/media-hub/news/messa-da-requiem.html2026-09-18T12:53:17.577Zhttps://www.chiesi.com/it/media-hub/news/sinfonia-n-9-di-ludwig-van-beethoven.html2026-09-18T12:53:17.745Zhttps://www.chiesi.com/it/media-hub/news/valery-gergiev.html2026-09-18T12:53:17.497Zhttps://www.chiesi.com/it/media-hub/news/verdi-off-2020.html2026-09-18T12:53:17.416Zhttps://www.chiesi.com/it/media-hub/news/chiesi-sostiene-la-dichiarazione-di-san-paolo-sulla-salute-planetaria.html2026-09-18T12:53:18.095Zhttps://www.chiesi.com/it/media-hub/news/global-policy-dai-unrulteriore-dimostrazione-dellrimpegno-di-chiesi.html2026-09-18T12:53:17.874Zhttps://www.chiesi.com/it/media-hub/news/il-gruppo-chiesi-e-su-twitter-21.html2026-09-18T12:53:17.788Zhttps://www.chiesi.com/it/media-hub/news/il-gruppo-chiesi-tra-le-aziende-lleader-della-sostenibilita-2021r-in-italia.html2026-09-18T12:53:18.008Zhttps://www.chiesi.com/it/media-hub/news/il-presidente-alberto-chiesi-ospite-al-roadshow-di-farmindustria.html2026-09-18T12:53:18.137Zhttps://www.chiesi.com/it/media-hub/news/macbeth-presentato-al-xx-festival-verdi-vince-il-xxxx-premio-franco-abbiati-della-critica-musicale-italiana.html2026-09-18T12:53:17.957Zhttps://www.chiesi.com/it/media-hub/news/nuovo-record-per-il-gruppo-chiesi-2c-che-si-conferma-prima-azienda-farmaceutica-italiana-per-numero-di-brevetti-depositati.html2026-09-18T12:53:17.831Zhttps://www.chiesi.com/it/media-hub/news/pelleas-et-melisande.html2026-09-18T12:53:17.915Zhttps://www.chiesi.com/it/media-hub/news/we-act-day-2021-torna-lrappuntamento-di-chiesi-verso-un-futuro-sostenibile.html2026-09-18T12:53:18.052Zhttps://www.chiesi.com/it/media-hub/news/cari-colleghi-2c-si-va-in-scena-21.html2026-09-18T12:53:18.52Zhttps://www.chiesi.com/it/media-hub/news/chiesi-si-aggiudica-il-diversity-leaders-award-per-il-3d-anno-consecutivo.html2026-09-18T12:53:18.18Zhttps://www.chiesi.com/it/media-hub/news/co2alizione-italia-non-solo-una-dichiarazione-di-intenti.html2026-09-18T12:53:18.604Zhttps://www.chiesi.com/it/media-hub/news/giornata-mondiale-della-prematurita-lrimpegno-di-chiesi.html2026-09-18T12:53:18.307Zhttps://www.chiesi.com/it/media-hub/news/il-gruppo-chiesi-tra-i-protagonisti-della-docuseries-dell-5c-ats-lhelping-the-world-to-breather.html2026-09-18T12:53:18.223Zhttps://www.chiesi.com/it/media-hub/news/innovare-per-la-salute-del-pianeta-e-per-quella-delle-persone-a-partire-dalle-piccole-cose.html2026-09-18T12:53:18.478Zhttps://www.chiesi.com/it/media-hub/news/l-5c-arte-della-cura.html2026-09-18T12:53:18.562Zhttps://www.chiesi.com/it/media-hub/news/la-strada-verso-una-sanita-sostenibile-e-resiliente.html2026-09-18T12:53:18.392Zhttps://www.chiesi.com/it/media-hub/news/nuovo-record-per-il-gruppo-chiesi-nel-2021-si-conferma-prima-azienda-farmaceutica-italiana-per-numero-di-brevetti-depositati.html2026-09-18T12:53:18.647Zhttps://www.chiesi.com/it/media-hub/news/partner-e-fornitori-protagonisti-del-vendor-day-2021-di-chiesi.html2026-09-18T12:53:18.265Zhttps://www.chiesi.com/it/media-hub/news/perche-il-mondo-biotech-ha-bisogno-di-investimenti.html2026-09-18T12:53:18.35Zhttps://www.chiesi.com/it/media-hub/news/un-manifesto-musicale-per-riscrivere-il-futuro.html2026-09-18T12:53:18.434Zhttps://www.chiesi.com/it/media-hub/news/alla-scoperta-dei-criteri-esg-environmental-social-e-governance-l-impegno-del-gruppo-chiesi.html2026-09-18T12:53:19.074Zhttps://www.chiesi.com/it/media-hub/news/dalle-cellule-al-packaging.html2026-09-18T12:53:18.989Zhttps://www.chiesi.com/it/media-hub/news/decarbonizzazione-del-settore-sanitario-l-amministrazione-biden-impegnata-verso-una-maggiore-resilienza-alla-lotta-al-cambiamento-climatico.html2026-09-18T12:53:18.862Zhttps://www.chiesi.com/it/media-hub/news/giacomo-chiesi-premiato-da-pharmavoice100.html2026-09-18T12:53:18.775Zhttps://www.chiesi.com/it/media-hub/news/il-gruppo-chiesi-e-la-parita-di-genere-una-realta-concreta-ora-certificata-da-bureau-veritas.html2026-09-18T12:53:19.167Zhttps://www.chiesi.com/it/media-hub/news/il-gruppo-chiesi-si-unisce-all-impegno-dell-amministrazione-biden-per-la-decarbonizzazione-del-settore-sanitario.html2026-09-18T12:53:18.691Zhttps://www.chiesi.com/it/media-hub/news/il-nuovo-ceo-ad-interim-di-chiesi.html2026-09-18T12:53:19.031Zhttps://www.chiesi.com/it/media-hub/news/l-alfabeto-della-sostenibilita.html2026-09-18T12:53:19.123Zhttps://www.chiesi.com/it/media-hub/news/programma-energize-un-impegno-condiviso-per-accelerare-lradozione-di-energie-rinnovabili-nel-settore-farmaceutico.html2026-09-18T12:53:18.947Zhttps://www.chiesi.com/it/media-hub/news/promuovere-l-innovazione-nel-campo-delle-malattie-rare-in-europa-chiesi-sostiene-il-bando-rdr-per-le-malattie-rare.html2026-09-18T12:53:18.818Zhttps://www.chiesi.com/it/media-hub/news/una-nuova-proposta-europea-per-tutelare-le-persone-e-il-pianeta-riducendo-gli-f-gas.html2026-09-18T12:53:18.734Zhttps://www.chiesi.com/it/media-hub/news/vendor-day-la-catena-del-valore-del-gruppo-chiesi-protagonista-del-futuro.html2026-09-18T12:53:18.904Zhttps://www.chiesi.com/it/media-hub/news/certificazione-leed-sostenibilita.html2026-09-18T12:53:19.461Zhttps://www.chiesi.com/it/media-hub/news/cosa-significa-essere-una-b-corp-la-scelta-di-chiesi-per-un-futuro-sostenibile.html2026-09-18T12:53:19.291Zhttps://www.chiesi.com/it/media-hub/news/giornata-internazionale-delle-malattie-rare.html2026-09-18T12:53:19.249Zhttps://www.chiesi.com/it/media-hub/news/nel-2022-il-gruppo-chiesi-si-conferma-prima-azienda-farmaceutica-italiana-per-numero-di-brevetti-depositati.html2026-09-18T12:53:19.333Zhttps://www.chiesi.com/it/media-hub/news/policy-diritti-umani.html2026-09-18T12:53:19.546Zhttps://www.chiesi.com/it/media-hub/news/report-sostenibilita-chiesi-2022-purpose-first.html2026-09-18T12:53:19.503Zhttps://www.chiesi.com/it/media-hub/news/solidarieta-dal-gruppo-chiesi-per-le-popolazioni-di-turchia-e-siria.html2026-09-18T12:53:19.208Zhttps://www.chiesi.com/it/media-hub/news/una-app-digitale-per-colmare-il-divario-di-accesso-alle-cure-per-la-bpco.html2026-09-18T12:53:19.42Zhttps://www.chiesi.com/it/media-hub/news/voto-del-parlamento-europeo-sulla-revisione-del-quadro-normativo-ue-sugli-f-gas-gli-obiettivi-climatici-richiedono-soluzioni-innovative.html2026-09-18T12:53:19.376Zhttps://www.chiesi.com/it/media-hub/news/certificazione-iso-37001-2016-sistema-di-gestione-anticorruzione.html2026-09-18T12:53:19.929Zhttps://www.chiesi.com/it/media-hub/news/chiesi-partnership-day-2023.html2026-09-18T12:53:19.67Zhttps://www.chiesi.com/it/media-hub/news/empowerment-femminile-parita-di-genere.html2026-09-18T12:53:19.796Zhttps://www.chiesi.com/it/media-hub/news/impegno-contro-molestie-violenza-sul-lavoro.html2026-09-18T12:53:19.753Zhttps://www.chiesi.com/it/media-hub/news/l-impegno-di-chiesi-per-la-parita-retributiva-tra-uomini-e-donne-ottiene-la-certificazione-fair-pay.html2026-09-18T12:53:19.839Zhttps://www.chiesi.com/it/media-hub/news/medaglia-ecovadis.html2026-09-18T12:53:19.881Zhttps://www.chiesi.com/it/media-hub/news/open-day-2023.html2026-09-18T12:53:19.628Zhttps://www.chiesi.com/it/media-hub/news/promuovere-la-diversita-e-l-inclusione-chiesi-affinity-networks.html2026-09-18T12:53:19.971Zhttps://www.chiesi.com/it/media-hub/news/ricertificazione-great-place-to-work.html2026-09-18T12:53:19.712Zhttps://www.chiesi.com/it/media-hub/news/statkraft-ppa-energia-rinnovabile.html2026-09-18T12:53:19.587Zhttps://www.chiesi.com/it/media-hub/news/certificazione-iso-37001-estensione-filiali.html2026-09-18T12:53:20.475Zhttps://www.chiesi.com/it/media-hub/news/certificazione-leed-ambienti-lavoro-sostenibili-persone-pianeta.html2026-09-18T12:53:20.426Zhttps://www.chiesi.com/it/media-hub/news/chiesi-presente-allramerican-thoracic-society-conference.html2026-09-18T12:53:20.013Zhttps://www.chiesi.com/it/media-hub/news/codice-interdipendenza-workshop-partner-rafforzare-relazioni.html2026-09-18T12:53:20.061Zhttps://www.chiesi.com/it/media-hub/news/gruppo-chiesi-conferma-medaglia-platino-ecovadis.html2026-09-18T12:53:20.157Zhttps://www.chiesi.com/it/media-hub/news/memoria-dr-paolo-chiesi.html2026-09-18T12:53:20.378Zhttps://www.chiesi.com/it/media-hub/news/sbti-obiettivi-riduzione-emissioni.html2026-09-18T12:53:20.109Zhttps://www.chiesi.com/it/media-hub/news/sostenibilita-inclusivita-nuovo-codice-interdipendenza.html2026-09-18T12:53:20.212Zhttps://www.chiesi.com/it/media-hub/news/tanimilast-fase-3-pilaster-bpco-risultati.html2026-09-18T12:53:20.523Zhttps://www.chiesi.com/it/media-hub/news/chiesi-oak-hill-bio-holdings-completano-arruolamento-dei-pazienti-nello-studio-fase2b-footprints.html2026-10-02T13:09:52.267Zhttps://www.chiesi.com/it/media-hub/news/chiesi-annuncia-la-partnership-con-abdi-ibrahim-in-turchia.html2026-10-02T13:19:31.006Zhttps://www.chiesi.com/it/media-hub/news/la-presidente-del-gruppo-chiesi-firma-una-lettera-aperta-a-sostegno-dell-innovazione-farmaceutica-in-europa.html2026-10-02T13:22:50.448Zhttps://www.chiesi.com/it/media-hub/news/chiesi-annuncia-importante-traguardo-nel-proprio-percorso-verso-net-zero-mhra-approva-primi-inalatori-pressurizzati-predosati-pmdi-contenenti-propellente-di-nuova-generazione-a-basso-gwp-global-warming-potential.html2026-10-05T15:13:02.927Zhttps://www.chiesi.com/it/media-hub/news/chiesi-restituisce-Gossamer-Bio-diritti-su-seralutinib-le-aziende-interrompono-accordo-di-collaborazione-e-licenza.html2026-10-02T13:25:02.808Zhttps://www.chiesi.com/it/media-hub/news/conclusione-programma-tanimilast.html2026-09-18T12:53:20.57Zhttps://www.chiesi.com/it/media-hub/news/fda-approva-trimbow-per-trattamento-di-mantenimento-dell-asma-negli-adulti.html2026-09-18T12:53:20.718Zhttps://www.chiesi.com/it/media-hub/news/seralutinib-fase-3-prosera-risultati-ipertensione-arteriosa-polmonare.html2026-09-18T12:53:20.668Zhttps://www.chiesi.com/it/media-hub/news/sottomissione-mhra-inalatore-minimo-impatto-carbonico.html2026-09-18T12:53:20.62Zhttps://www.chiesi.com/it/media-hub/storie-e-prospettive/ogni-neonato-conta-ogni-respiro-conta.html2026-09-29T09:15:53.727Zhttps://www.chiesi.com/it/media-hub/storie-e-prospettive/promuovere-la-health-equity.html2026-09-29T13:16:28.561Zhttps://www.chiesi.com/it/media-hub/storie-e-prospettive/alla-scoperta-del-nostro-biotech-centre-of-excellence.html2026-09-29T09:29:06.428Zhttps://www.chiesi.com/it/media-hub/storie-e-prospettive/oltre-i-confini-di-chiesi.html2026-09-30T10:21:14.413Zhttps://www.chiesi.com/it/media-hub/storie-e-prospettive/Il-nostro-percorso-verso-net-zero.html2026-09-29T13:22:33.396Zhttps://www.chiesi.com/it/media-hub/storie-e-prospettive/rendere-visibile-l-invisibile-the-digital-lung-twin.html2026-09-30T08:55:32.194Zhttps://www.chiesi.com/it/medical-information.html2026-10-02T14:43:40.879Zhttps://www.chiesi.com/it/il-nostro-approccio.html2026-10-06T10:55:59.064Zhttps://www.chiesi.com/it/le-nostre-soluzioni.html2026-10-06T10:19:05.557Zhttps://www.chiesi.com/it/le-nostre-soluzioni/salute-respiratoria.html2026-10-06T14:17:52.688Zhttps://www.chiesi.com/it/le-nostre-soluzioni/malattie-rare.html2026-10-06T14:19:15.536Zhttps://www.chiesi.com/it/le-nostre-soluzioni/la-nostra-pipeline.html2026-09-29T08:44:42.282Zhttps://www.chiesi.com/it/le-nostre-soluzioni/cure-specialistiche.html2026-10-06T14:15:42.433Zhttps://www.chiesi.com/it/diventa-nostro-partner.html2026-10-06T11:03:55.468Zhttps://www.chiesi.com/it/il-nostro-purpose.html2026-09-30T13:35:35.45Zhttps://www.chiesi.com/it/il-nostro-purpose/ambiente.html2026-10-06T10:34:28.93Zhttps://www.chiesi.com/it/il-nostro-purpose/pazienti.html2026-10-06T10:33:22.956Zhttps://www.chiesi.com/it/il-nostro-purpose/persone.html2026-09-30T13:17:55.388Zhttps://www.chiesi.com/it/il-nostro-purpose/creazione-di-valore.html2026-10-06T10:36:30.479Zhttps://www.chiesi.com/it/sitemap.html2026-09-18T12:53:28.594Zhttps://www.chiesi.com/it/termini-di-utilizzo-social-media.html2026-09-23T08:34:42.441Zhttps://www.chiesi.com/it/speakup-and-beheard.html2026-09-23T12:42:57.609Zhttps://www.chiesi.com/it/sustainability.html2026-10-06T11:05:17.848Zhttps://www.chiesi.com/it/termini-di-utilizzo-sito-web.html2026-10-02T16:04:46.587Zhttps://www.chiesi.com/it/accessibilita.html2026-09-24T15:07:33.107Zhttps://www.chiesi.com/it/archivio.html2026-10-02T10:31:38.406Zhttps://www.chiesi.com/it/farmacovigilanza.html2026-09-27T19:27:58.596Zhttps://www.chiesi.com/it/privacy.html2026-10-02T10:21:23.503Z